Stockreport

Hoth Therapeutics Commences Next Phase of VNLG-152 Study

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK, April 9, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced initiating the next phase of its study of VN [Read more]